Detalhe da pesquisa
1.
A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.
BMC Cancer
; 15: 171, 2015 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25881079